欧洲器官保存液市场预测至 2031 年 - 区域分析 - 按产品(威斯康星大学溶液、Custodiol HTK、Perfadex、低温溶胶等)、应用(静态冷藏、低温机器灌注、常温机器灌注等)、类型(肾脏、肝脏、肺、心脏等)和最终用户(器官移植中心、医院和专科诊所)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2028


No. of Pages: 140    |    Report Code: TIPRE00025779    |    Category: Life Sciences

Europe Organ Preservation Solution Market
2023 年欧洲器官保存液市场价值为 86,522.54 千美元,预计到 2031 年将达到 1,59,990.22 千美元;预计 2023 年至 2031 年的复合年增长率为 8.1%。

慢性病患病率不断上升推动欧洲器官保存液市场发展

慢性疾病可能是先天性的,也可能是后天性的,会随着时间的推移导致器官逐渐受损。慢性疾病通常不会自行解决,但有一些方法可以减缓该疾病造成的损害。这种损害可能需要几十年才能积累到明显影响患者器官功能或需要医疗干预的程度。慢性肾病 (CKD) 是一种常见且可能致命的疾病,全球约有十分之一的人患有此病。脂肪肝和丙型肝炎等慢性肝病是慢性肝功能衰竭的常见原因。世界卫生组织 (WHO) 估计,全球约有 5000 万人感染慢性丙型肝炎病毒,每年新增感染病例约 100 万例。2022 年,约有 24.2 万人死于丙型肝炎,主要原因是肝硬化和肝细胞癌。慢性心脏病,包括冠状动脉疾病和先天性心脏病,可导致进行性心力衰竭。根据英国心脏基金会发布的《全球心脏和循环系统疾病情况说明书》,先天性心脏病是全球儿童健康中一个迅速出现的问题。全球每 110 个新生儿中约有 1 个被诊断出患有先天性心脏病,婴儿成年后确诊的病例可能高达每年 120 万例,平均每天 3300 例(或每 26 秒就有一例)。因此,随着与慢性病相关的器官移植程序需求的激增,对器官保存解决方案的需求也在增加。

欧洲器官保存解决方案市场概览

欧洲器官保存解决方案市场分为德国、法国、英国、西班牙、意大利和欧洲其他地区。预计在预测期内,德国和意大利将在区域市场中占据相当大的市场份额。未来几年,法国、英国和西班牙市场可能会迎来丰厚的机遇。器官移植数量的增加、导致器官衰竭的慢性病患病率的上升以及器官保存解决方案的技术进步推动了欧洲器官保存解决方案市场的增长。预计德国将成为全球器官保存解决方案市场增长的主要贡献者之一。根据“世界人口老龄化”,2017 年德国总人口中近 28.0% 为 60 岁及以上,预计到 2050 年老龄人口将上升到近 37.6%。慢性病的患病率随着年龄的增长而增加。此外,随着年龄的增长,许多器官开始出现故障或功能障碍,从而增加了对器官移植程序的需求。因此,随着老年人口的增加,对器官保存解决方案的需求也在增长。

欧洲器官保存解决方案市场收入及预测至 2031 年(千美元)

欧洲器官保存解决方案市场细分

欧洲器官保存解决方案市场分为产品、应用、类型、最终用户和国家。

根据产品,欧洲器官保存解决方案市场分为威斯康星大学解决方案、custodiol HTK、Perfadex、Hypothermosol 等。威斯康星大学部门在 2023 年占据了最大的市场份额。

在应用方面,欧洲器官保存解决方案市场分为静态冷藏、低温机器灌注、常温机器灌注等。静态冷藏部分在 2023 年占据最大的市场份额。

按类型,欧洲器官保存解决方案市场分为肾脏、肝脏、肺、心脏和其他。肾脏部分在 2023 年占据最大的市场份额。

根据最终用户,欧洲器官保存解决方案市场细分为器官移植中心、医院和专科诊所。器官移植中心部分在 2023 年占据最大的市场份额。

按国家/地区,欧洲器官保存解决方案市场细分为英国、德国、法国、意大利、西班牙和欧洲其他地区。德国在 2023 年占据了欧洲器官保存解决方案市场的主导地位。

XVIVO Perfusion、TransMedics、OrganOx Limited、Paragonix Technologies, Inc、Dr. Franz Koehler Chemie GmbH 和 Accord Healthcare 是欧洲器官保存解决方案市场的领先公司。

Europe Organ Preservation Solution Strategic Insights

Strategic insights for Europe Organ Preservation Solution involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-organ-preservation-solutions-market-strategic-framework.webp
Get more information on this report

Europe Organ Preservation Solution Report Scope

Report Attribute Details
Market size in 2023 US$ 69.90 Million
Market Size by 2028 US$ 99.51 Million
Global CAGR (2023 - 2028) 7.3%
Historical Data 2021-2022
Forecast period 2024-2028
Segments Covered By 类型
  • 威斯康星大学溶液
  • Custodiol HTK
  • Perfadex
  • Hypothermosol
By 应用
  • 静态冷藏
  • 低温机灌注
  • 常温机灌注
By 器官类型
  • 肾
  • 肝
  • 肺
  • 心脏
By 最终用户
  • 器官移植中心
  • 医院
  • 专科诊所
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Accord Healthcare
  • Dr. Franz Koehler Chemie GmbH
  • Lifeline Scientific, Inc
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • TransMedics
  • Get more information on this report

    Europe Organ Preservation Solution Regional Insights

    The regional scope of Europe Organ Preservation Solution refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-organ-preservation-solutions-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Organ Preservation Solution Market

    • XVIVO Perfusion
    • TransMedics
    • OrganOx Limited
    • Paragonix Technologies, Inc
    • Dr. Franz Koehler Chemie GmbH
    • Accord Healthcare
    Frequently Asked Questions
    How big is the Europe Organ Preservation Solution Market?

    The Europe Organ Preservation Solution Market is valued at US$ 69.90 Million in 2023, it is projected to reach US$ 99.51 Million by 2028.

    What is the CAGR for Europe Organ Preservation Solution Market by (2023 - 2028)?

    As per our report Europe Organ Preservation Solution Market, the market size is valued at US$ 69.90 Million in 2023, projecting it to reach US$ 99.51 Million by 2028. This translates to a CAGR of approximately 7.3% during the forecast period.

    What segments are covered in this report?

    The Europe Organ Preservation Solution Market report typically cover these key segments-

  • 类型 (威斯康星大学溶液, Custodiol HTK, Perfadex, Hypothermosol)
  • 应用 (静态冷藏, 低温机灌注, 常温机灌注)
  • 器官类型 (肾, 肝, 肺, 心脏)
  • What is the historic period, base year, and forecast period taken for Europe Organ Preservation Solution Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Organ Preservation Solution Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2028
  • Who are the major players in Europe Organ Preservation Solution Market?

    The Europe Organ Preservation Solution Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Accord Healthcare
  • Dr. Franz Koehler Chemie GmbH
  • Lifeline Scientific, Inc
  • OrganOx Limited
  • Paragonix Technologies, Inc
  • TransMedics
  • Who should buy this report?

    The Europe Organ Preservation Solution Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Organ Preservation Solution Market value chain can benefit from the information contained in a comprehensive market report.